BioLargo Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
167.90
111.50
127.60
281.10
516.20
1,364
Cost of Goods Sold (COGS) incl. D&A
40.60
66.90
73.00
119.60
352.60
793
Gross Income
127.40
44.60
54.60
161.50
163.70
571
SG&A Expense
2,747.00
3,436.00
4,236.10
5,096.40
6,058.70
6,983
EBIT
2,619.70
3,391.40
4,181.50
4,934.90
5,895.00
6,412
Unusual Expense
-
-
-
171.80
-
1,021
Interest Expense
281.60
348.20
994.70
3,129.10
3,862.20
3,494
Pretax Income
2,901.20
3,739.60
5,077.00
8,074.30
9,617.60
10,769
Income Tax
-
-
-
-
71.10
73
Consolidated Net Income
2,901.20
3,739.60
5,077.00
8,074.30
9,546.50
10,696
Net Income
2,528.30
3,692.10
5,056.00
7,839.70
9,117.30
10,221
Net Income After Extraordinaries
2,528.30
3,692.10
5,056.00
7,839.70
9,117.30
10,221
Net Income Available to Common
2,528.30
3,692.10
5,056.00
7,839.70
9,117.30
10,221
EPS (Basic)
0.03
0.05
0.06
0.09
0.09
0.08
Basic Shares Outstanding
72,950.20
80,017.00
84,112.40
87,936.80
98,941.20
122,000.90
EPS (Diluted)
0.03
0.05
0.06
0.09
0.09
0.08
Diluted Shares Outstanding
72,950.20
80,017.00
84,112.40
87,936.80
98,941.20
122,000.90
EBITDA
2,608.70
3,380.50
4,170.60
4,919.00
5,865.20
6,362
Minority Interest Expense
372.90
47.50
21.10
234.60
429.20
475
About BioLargo
View Profile
